Table 3 Secondary outcomes across all study groups
Outcome | Mean change from baseline (95% CI) | Â | Â | ILM vs. SILM groups | ILM vs. WLC groups | |||
|---|---|---|---|---|---|---|---|---|
ILM (n = 56) | SILM (n = 56) | WLC (n = 28) |  | Difference (95%CI) | aP value | Difference (95%CI) | aP value | |
PSQI | Â | Â | Â | Â | Â | Â | Â | Â |
week 3 | -1.24 (-2.09,-0.40) | -0.55Â (-1.38,0.28) | 0.44Â (-0.50,1.38) | Â | -0.62Â (-1.72,0.49) | 0.2740 | -1.60Â (-2.92,-0.28) | 0.0176 |
week 6 | -2.06 (-2.93,-1.19) | -0.98Â (-1.80,0.16) | 0.59Â (-0.75,1.94) | Â | -0.97Â (-2.16,0.23) | 0.1111 | -2.51Â (-3.92,-1.10) | 0.0006 |
week 12 | -2.12 (-3.15,-1.09) | -1.08Â (-2.01,-0.15) | -0.19Â (-1.60,1.23) | Â | -0.91Â (-2.27,0.44) | 0.1857 | -1.70Â (-3.31,-0.10) | 0.0373 |
week 18 | -3.00 (-4.06,-1.94) | -1.00Â (-2.00,-0.00) | -0.70Â (-1.78,0.38) | Â | -1.85Â (-3.18,-0.51) | 0.0070 | -2.11Â (-3.70,-0.52) | 0.0097 |
FACT-B | ||||||||
week 3 | 3.88Â (0.25,7.50) | 2.67Â (0.87,4.52) | 0.37Â (-1.49,1.56) | Â | 1.03Â (-2.51,4.57) | 0.5661 | 3.64Â (-0.56,7.84) | 0.0885 |
week 6 | 6.73Â (2.52,10.95) | 2.80Â (-0.12,5.60) | 1.22Â (-1.12,3.56) | Â | 3.72Â (-0.70,8.14) | 0.0987 | 5.12Â (-0.02,10.45) | 0.0510 |
week 12 | 7.27Â (3.16,11.37) | 5.24Â (3.19,7.29) | 2.22Â (-0.99,5.44) | Â | 1.80Â (-2.34,5.94) | 0.3919 | 4.82Â (-0.09,9.73) | 0.0545 |
week 18 | 7.86Â (3.94,11.77) | 4.39Â (1.24,7.54) | 2.44Â (-0.39,5.28) | Â | 3.26Â (-1.21,7.72) | 0.1518 | 5.12Â (-0.19,10.43) | 0.0585 |